CAPTOPRIL AT 50-MG AS WELL AS AT 100-MG ONCE A DAY REDUCES BLOOD-PRESSURE FOR UP TO 24-H - A DOUBLE-BLIND RANDOMIZED CROSSOVER STUDY IN MILD TO MODERATE HYPERTENSIVES

被引：5
|
作者：
SALVETTI, A [1 ]
CIRCO, A [1 ]
RACITI, S [1 ]
GULIZIA, M [1 ]
CARDILLO, R [1 ]
MICELI, S [1 ]
BOTTA, G [1 ]
机构：
[1] OSPED SAN LUIGI,CATANIA,ITALY
来源：
JOURNAL OF HYPERTENSION | 1988年 / 6卷
关键词：
D O I：
10.1097/00004872-198812040-00209
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S666 / S668
页数：3
相关论文
共 33 条
  • [21] EVALUATION BY 24-HOUR AMBULATORY BLOOD-PRESSURE MONITORING OF EFFICACY OF BENAZEPRIL 20-MG PLUS HYDROCHLOROTHIAZIDE 25-MG FIXED COMBINATION AS COMPARED TO CAPTOPRIL 25-MG PLUS HYDROCHLOROTHIAZIDE 25-MG FIXED COMBINATION IN TREATING MILD-TO-MODERATE HYPERTENSION - A DOUBLE-BLIND, WITHIN-PATIENT, PLACEBO-CONTROLLED STUDY (VOL 24, PG 687, 1994)
    FOGARI, R
    ZOPPI, A
    TETTAMANTI, F
    TETTAMANZI, D
    LUSARDI, P
    MOTOLESE, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (02) : 345 - 345
  • [22] Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
    Olie, Jean-Pierre
    Gourion, David
    Montagne, Agnes
    Rostin, Michel
    Poirier, Marie-France
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 71 - 79
  • [23] 1ST-DOSE BLOOD-PRESSURE RESPONSE IN MILD-TO-MODERATE HEART-FAILURE - A RANDOMIZED, DOUBLE-BLIND-STUDY COMPARING ENALAPRIL WITH LISINOPRIL BY 24-HOUR NONINVASIVE BLOOD-PRESSURE MONITORING
    OTTERSTAD, JE
    FROELAND, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (10): : C132 - C134
  • [24] ANTIHYPERTENSIVE EFFICACY AND TROUGH TO PEAK RATIOS OF FELODIPINE ER 5 AND 10MG IN PATIENTS WITH PRIMARY HYPERTENSION - A DOUBLE-BLIND, CROSSOVER STUDY USING AMBULATORY BLOOD-PRESSURE MEASUREMENT
    LEDERLE, RM
    WETZCHEWALD, D
    LEDERLE, E
    DRUG INVESTIGATION, 1994, 8 (06): : 369 - 376
  • [25] COMPARATIVE-STUDY OF THE EFFICACY OF 100 MG OF CATOPRIL TAKEN ONCE DAILY VS 50 MG OF THE SAME DRUG TAKEN TWICE DAILY, AS REFLECTED IN REGULAR AMBULATORY BLOOD-PRESSURE READINGS RECORDED OVER A PERIOD OF 24 HOURS
    DEGAUDEMARIS, R
    BATTISTELLA, P
    SICHE, JP
    BLATIER, JF
    MALLION, JM
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1987, 80 (06): : 1069 - 1069
  • [26] 24 HOUR BLOOD PRESSURE RESPONSE TO LOWER DOSE (30MG) FIMASARTAN. AN 8-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VALSARTAN 80MG-REFERENCED, PARALLEL-GROUPED STUDY
    Lee, H.
    Kim, C.
    Song, J.
    Chae, S.
    Jeong, M.
    Kim, D.
    Oh, B.
    JOURNAL OF HYPERTENSION, 2015, 33 : E456 - E456
  • [27] Managing Functional and Cognitive Decline in Patients with Mild-to-Moderate Alzheimer's Disease: A 48-Week, Randomized, Double-Blind Evaluation of 13.3 mg/24 h (15 cm2) Versus 9.5 mg/24 h (10 cm2) Rivastigmine Patch
    Cummings, Jeffrey
    Froelich, Lutz
    Black, Sandra
    Bakchine, Serge
    Bellelli, Giuseppe
    Molinuevo, Jose
    Kressig, Reto
    Downs, Pamela
    Caputo, Angelika
    Strohmaier, Christine
    NEUROLOGY, 2012, 78
  • [28] THE EFFECT OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE ON 24-H BLOOD PRESSURE VARIATION: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSS OVER STUDY
    Kumarathurai, P.
    Anholm, C.
    Kristiansen, O. K.
    Nielsen, O. W.
    Haugaard, S. B.
    Sajadieh, A.
    JOURNAL OF HYPERTENSION, 2016, 34 : E42 - E43
  • [29] Managing functional and cognitive decline in patients with mild-to-moderate Alzheimer's disease: a 48-week, randomized, double-blind evaluation of 13.3 mg/24 h (15 cm2) versus 9.5 mg/24 h (10 cm2) rivastigmine patch.
    Cummings, J.
    Froelich, L.
    Black, S. E.
    Bakchine, S.
    Bellelli, G.
    Molinuevo, J. L.
    Kressig, R. W.
    Downs, P.
    Caputo, A.
    Somogyi, M.
    Strohmaier, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S196 - S196
  • [30] Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study
    Kumarathurai, Preman
    Anholm, Christian
    Fabricius-Bjerre, Andreas
    Nielsen, Olav W.
    Kristiansen, Ole
    Madsbad, Sten
    Haugaard, Steen B.
    Sajadieh, Ahmad
    JOURNAL OF HYPERTENSION, 2017, 35 (05) : 1070 - 1078
1234